Pulmonary Cystic Echinococcosis: Two Cases, Two Treatment Options
Open Access
- 19 February 2020
- journal article
- Published by Oman Medical Journal in Oman Medical Journal
- Vol. 35 (1), e95
- https://doi.org/10.5001/omj.2020.13
Abstract
Cystic echinococcosis (CE) is a zoonotic infection caused by the tapeworm of the genus Echinococcus, a cestode endemic in many parts of the world. CE can affect any organ, with the lung being the second most commonly affected organ after the liver. For the management of pulmonary CE, guidelines recommend surgical resection of cysts with adjuvant anti-helminthic therapy. In cases where surgery is not possible, medical therapy alone can be used. However, to date, there is a paucity of data to advocate for one modality over the other. Here, we report two cases of pulmonary CE caused by E. granulosus, one was managed with surgery and adjuvant anti-helminthic therapy while the other was managed with medical therapy alone. Both patients had clinical and radiological resolution outlining the role and efficacy of both modalities of therapy.Keywords
This publication has 8 references indexed in Scilit:
- Cystic EchinococcosisJournal of Clinical Microbiology, 2016
- Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humansActa Tropica, 2010
- Pulmonary cystic echinococcosisCurrent Opinion in Pulmonary Medicine, 2010
- Anthelminthic treatment: An adjuvant therapeutic strategy against Echinococcus granulosusParasitology International, 2009
- Echinococcosis: a reviewInternational Journal of Infectious Diseases, 2009
- International classification of ultrasound images in cystic echinococcosis for application in clinical and field epidemiological settingsActa Tropica, 2003
- Laboratory Diagnosis of Cystic Hydatic DiseaseWorld Journal of Surgery, 2001
- The seroprevalence of cystic hydatidosis in Oman.Pathogens and Global Health, 1999